Inactive Instrument

Press Releases Intellego Technologies AB

Equities

INT

SE0016075063

Biotechnology & Medical Research

Press Releases

04-08	Notice of extraordinary general meeting and first control meeting of Intellego Technologies AB (publ)	AQ
03-04	Decision on delisting from the Nasdaq First North Growth Market trading platform will be executed on 4 March 2026	AQ
03-04	The Disciplinary Committee of Nasdaq Stockholm has decided to delist the shares in Intellego Technologies AB (publ) from Nasdaq First North Growth Market	AQ
02-26	The board of directors of Intellego Technologies AB (publ) resolves on staff cuts	AQ
02-23	The board of directors of Intellego Technologies AB (publ) dismisses the CEO	AQ
02-23	Bulletin from the extraordinary general meeting of Intellego Technologies AB (publ)	AQ
02-20	Financial Statements from Intellego Technologies AB 2025	AQ
02-19	Follow-up independent forensic report concerning 2024 Leads Intellego to File an Additional Criminal Complaint Against Former CEO	AQ
02-18	Invitation to presentation of Financial Statements 2025 – Intellego Technologies AB	AQ
02-16	Proposed new board of directors for the extraordinary general meeting of Intellego Technologies AB	AQ
01-30	Independent forensic investigation of Intellego Technologies’ financial information and corporate communication presented today	AQ
01-20	Nasdaq requests Disciplinary Committee to delist Intellego	AQ
01-15	Clarification regarding Intellego Technologies' police report against its former CEO and founder	AQ
01-12	INVITATION TO PRESS BRIEFING – PRESENTATION OF KPMG’S CONCLUSIONS FROM THE INVESTIGATION OF INTELLEGO	AQ
01-12	Intellego files a police report on former CEO	AQ
01-12	NOTICE OF EXTRAORDINARY GENERAL MEETING IN INTELLEGO TECHNOLOGIES AB (PUBL)	AQ
01-03	Intellego announces cancellation of MoveoMed transaction	AQ
12-30	Intellego’s partner HAI Solutions has received FDA approval for QIKcap	AQ
12-18	Update from Intellego	AQ
12-17	Board Member Johan Möllerström refrains from performing his duties during the investigation period	AQ
12-17	Heights Capital Management poses claim on Intellego Technologies AB	AQ
12-15	Intellego Technologies’ board member Johan Möllerström has been notified of suspicion of gross fraud	AQ
12-10	Intellego appeals asset freeze	AQ
12-04	Intellego granted additional time to respond to Nasdaq	AQ
11-27	Deloitte AB intends to submit a report of suspicion of accounting fraud	AQ